French medico-administrative data to identify the care pathways of women with breast cancer by Lefeuvre, D., MD, Le Bihan-Benjamin, C., MD, Pauporté, I., PhD, Medioni, J., MD PhD, Bousquet, P.J., MD PhD

Get full text

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial by Pivot, Xavier, Prof, Romieu, Gilles, MD, Debled, Marc, MD, Pierga, Jean-Yves, Prof, Kerbrat, Pierre, Prof, Bachelot, Thomas, MD, Lortholary, Alain, MD, Espié, Marc, MD, Fumoleau, Pierre, Prof, Serin, Daniel, MD, Jacquin, Jean-Philippe, MD, Jouannaud, Christelle, MD, Rios, Maria, MD, Abadie-Lacourtoisie, Sophie, MD, Tubiana-Mathieu, Nicole, Prof, Cany, Laurent, MD, Catala, Stéphanie, MD, Khayat, David, Prof, Pauporté, Iris, PhD, Kramar, Andrew, PhD

Get full text